Related Experiment Video
Updated: Jun 29, 2025
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Local Sociocultural Practice Specific Financial Toxicity Assessment Tool for Cancer: An Emerging Need
Parth Sharma1, Muttacaud Ramakrishnan Rajagopal1, Enrique Soto-Perez-de-Celis1
1Parth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.
Abstract:
It is relevant to study the financial toxicity of cancer to address it. However, the existing tools fail to capture the financial destruction of cancer on patients and their families in resource-limited countries. The authors discuss the need for a new tool in this article.
Insights
Cancer financial toxicity is a major concern, but current tools are inadequate for resource-limited settings. This article highlights the urgent need for a new assessment tool to address the financial burden on patients and families.
Area of Science:
- Oncology
- Health Economics
- Health Equity
Background:
- Financial toxicity significantly impacts cancer patients and their families.
- Existing assessment tools often fail to capture the full economic burden in diverse settings.
- Resource-limited countries face unique challenges in managing cancer-related financial distress.
Discussion:
- The inadequacy of current financial toxicity tools in low- and middle-income countries (LMICs) necessitates a novel approach.
- Understanding the specific financial burdens in LMICs is crucial for developing targeted interventions.
- A new tool must be sensitive to the socioeconomic realities of diverse patient populations.
Key Insights:
- Current financial toxicity assessment tools lack applicability in resource-limited settings.
- There is a critical gap in understanding the comprehensive financial impact of cancer globally.
- Developing culturally and economically relevant tools is essential for equitable cancer care.
Outlook:
- Future research should focus on co-designing and validating new financial toxicity tools for LMICs.
- Policy interventions are needed to mitigate the financial toxicity of cancer.
- Improved financial assessment tools can lead to better patient support and outcomes.
Related Concept Videos
01:21Cancer Survival Analysis
01:27Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...